Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression.
about
Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsT follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathwayCostimulatory pathways in transplantation.Immunomodulatory Functions of BTLA and HVEM Govern Induction of Extrathymic Regulatory T Cells and Tolerance by Dendritic Cells.Challenges and future perspectives of T cell immunotherapy in cancerThe role of coinhibitory signaling pathways in transplantation and toleranceLow B and T lymphocyte attenuator expression on CD4+ T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort studyThe signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulationB and T lymphocyte attenuator inhibits LPS-induced endotoxic shock by suppressing Toll-like receptor 4 signaling in innate immune cells.The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory ResponsesRegulatory T Cell Dysfunction Acquiesces to BTLA+ Regulatory B Cells Subsequent to Oral Intervention in Experimental Autoimmune EncephalomyelitisAdvances in targeting cell surface signalling molecules for immune modulationTNFRSF14 aberrations in follicular lymphoma increase clinically significant allogeneic T-cell responses.Selective blockade of herpesvirus entry mediator-B and T lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction.T cell exhaustion: from pathophysiological basics to tumor immunotherapy.Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.Divide and conquer: Blocking graft versus host but not graft versus leukemia T cells with agonist BTLA co-inhibitory signals.BTLA identifies dysfunctional PD-1-expressing CD4+ T cells in human hepatocellular carcinoma.Attenuation by targeting the B- and T-cell attenuator.Role of B and T Lymphocyte Attenuator in Renal Transplant Recipients with Biopsy-Proven Acute Rejection.Immune aspects of sepsis and hope for new therapeutics.A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.Immune Checkpoints as Therapeutic Targets in Autoimmunity
P2860
Q26782799-B19B6714-8700-40DA-B2FA-9F966AE5D0F0Q33920121-7A31124D-F4D5-4B22-BC73-ECDAC28EA290Q34187594-4937AB62-B8C0-461E-B92E-AC1C5232809AQ34543668-98FA4DB1-98FE-409A-96FA-6858B66705CAQ35843507-945F446E-6EBE-4F23-9AF5-017CB79C2489Q35928357-46EA0AE9-1D3E-4463-A06C-209B34D46114Q36016266-7A2C9FFD-4F14-452F-A683-76AFDF55E5D2Q36053977-B24F4694-71CC-4537-96AD-5A9C71C52818Q36729527-00F53D53-4F14-4F81-90B3-EEC46063CD44Q36940326-3F597D33-7C62-4FC7-91BF-BA00549C9DA1Q36971195-365C5F5E-49E3-4FB6-859E-16C350F2F66AQ36973787-8E138AC1-89E2-4850-8AED-6383E1B1B865Q37116255-70D1236B-ACAC-4437-8338-858519A9DCF3Q37585824-4B6A93C9-0F22-4CC4-89B4-84CD253158FDQ39078341-34C5EF0A-449A-4DCE-8490-BDD41B5EF9B5Q39239092-46FC22D5-23C5-4C41-A829-7C33E385E7CBQ39753388-557BF188-E1F6-455C-BA88-6B557104F59AQ40357836-71BABB6B-E434-4887-A98B-697C397B0D65Q40462270-773A40AB-D303-452A-9A25-5C6A7D1315BAQ47551136-5165968B-5743-4EFF-B29D-E3D974A16690Q47565961-DFFA006C-21D5-4EC0-A522-93C7A1ABF992Q47603310-E4BEA7DA-10B6-4303-BCD3-40543980CB19Q48273861-A5D0FEC9-4595-4D1C-A66D-FEBF003F6A5AQ57817465-B2C8F81D-C252-4585-954E-D08F74232752
P2860
Targeting of B and T lymphocyte associated (BTLA) prevents graft-versus-host disease without global immunosuppression.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Targeting of B and T lymphocyt ...... hout global immunosuppression.
@ast
Targeting of B and T lymphocyt ...... hout global immunosuppression.
@en
Targeting of B and T lymphocyte associated
@nl
type
label
Targeting of B and T lymphocyt ...... hout global immunosuppression.
@ast
Targeting of B and T lymphocyt ...... hout global immunosuppression.
@en
Targeting of B and T lymphocyte associated
@nl
prefLabel
Targeting of B and T lymphocyt ...... hout global immunosuppression.
@ast
Targeting of B and T lymphocyt ...... hout global immunosuppression.
@en
Targeting of B and T lymphocyte associated
@nl
P2093
P2860
P50
P356
P1476
Targeting of B and T lymphocyt ...... hout global immunosuppression.
@en
P2093
Aaron S Rapaport
Brian T Edelson
Kenneth M Murphy
Matthias Stelljes
Michelle M Sandau
Mona Mashayekhi
Stephanie K Lathrop
Theresa L Murphy
P2860
P304
P356
10.1084/JEM.20102017
P407
P577
2010-11-15T00:00:00Z